Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Gynecologic Cancer × Drug Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 11 Neoplasms 9 Pancreatic Neoplasms 7 Neoplasm Metastasis 7 Squamous Cell Carcinoma of Head and Neck 6 Ovarian Neoplasms 6 Lung Neoplasms 5 Leukemia, Myeloid, Acute 5 Leukemia 5 Glioblastoma 5 Colorectal Neoplasms 5 Stomach Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Head and Neck Neoplasms 4 Central Nervous System Neoplasms 4 Brain Neoplasms 4 Recurrence 3 Neuroblastoma 3 Lymphoma, Non-Hodgkin 3 Lymphoma 3 Gliosarcoma 3 Fallopian Tube Neoplasms 3 Esophageal Neoplasms 3 Breast Neoplasms 3 Astrocytoma 3 Unspecified Adult Solid Tumor, Protocol Specific 2 Mesothelioma, Malignant 2 Kidney Neoplasms 2 Gastrointestinal Neoplasms 2 Esophageal Squamous Cell Carcinoma 2

Interventions

genexol-PM 1 gadobutrol 1 Population Groups 1 NK Cell Lectin-Like Receptor Subfamily B 1 Exercise 1 Drug Therapy 1 Counseling 1 Cisplatin 1 AGuIX 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03308604 2021-07-07

NANOCOL

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1 Unknown

Gynecologic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡